NEOSURF 100MG INJECTION 3 ML

How NEOSURF 100MG INJECTION 3 ML Works

• NEOSURF 100MG INJECTION 3 ML contains Surfactant, a naturally occurring substance in the lungs. Its primary function is to reduce surface tension in the alveoli, the tiny air sacs in the lungs where gas exchange occurs. In premature infants, particularly those born before 34 weeks of gestation, the lungs may not have developed sufficiently to produce enough surfactant on their own. This deficiency leads to a condition called Infant Respiratory Distress Syndrome (IRDS), also known as Hyaline Membrane Disease.
• In IRDS, the lack of surfactant causes the alveoli to collapse upon exhalation. This collapse makes it extremely difficult for the infant to breathe, requiring them to exert a great deal of effort with each breath. The increased effort can lead to exhaustion and respiratory failure. Furthermore, the collapsed alveoli reduce the surface area available for gas exchange, leading to decreased oxygen levels in the blood and increased carbon dioxide levels.
• NEOSURF 100MG INJECTION 3 ML works by replenishing the deficient surfactant in the infant's lungs. When administered, the surfactant molecules spread across the surface of the alveoli, reducing surface tension. This allows the alveoli to remain open, or at least partially open, at the end of exhalation. By preventing alveolar collapse, NEOSURF 100MG INJECTION 3 ML significantly reduces the effort required for the infant to breathe.
• The reduction in breathing effort allows the infant to conserve energy and reduces the risk of respiratory failure. Furthermore, with the alveoli remaining open, a greater surface area is available for gas exchange. This leads to improved oxygen levels in the blood and reduced carbon dioxide levels. Ultimately, NEOSURF 100MG INJECTION 3 ML helps to stabilize the infant's respiratory function, allowing them to breathe more easily and effectively, and supporting their overall health and development.
• The administration of NEOSURF 100MG INJECTION 3 ML is typically performed by trained medical professionals in a neonatal intensive care unit (NICU). The injection is administered directly into the infant's trachea, usually via an endotracheal tube. The dosage and frequency of administration will depend on the infant's weight and the severity of their condition. Following administration, the infant's respiratory status will be closely monitored to assess their response to the treatment.
• In summary, NEOSURF 100MG INJECTION 3 ML addresses IRDS by supplying the lungs with the necessary surfactant to reduce surface tension. This action prevents alveolar collapse, eases breathing effort, enhances gas exchange, and stabilizes respiratory function, thereby greatly improving the prognosis for premature infants suffering from this challenging condition.

Possible side effects of Neosurf 100mg Injection (Beractant) may include: * Breathing difficulties (apnea) * Slow heart rate (bradycardia) * Decreased oxygen saturation * Endotracheal tube blockage * Lung Hemorrhage * Mucus plugging * Pulmonary air leaks * Infection * Intracranial hemorrhage * Seizures * Acidosis Less common side effects may include: * Hypertension * Hypotension * Pallor * Peripheral vasoconstriction

• As this medication is administered by a healthcare professional, the chances of missing a dose are low. However, if you believe you have missed a scheduled dose, inform your doctor or healthcare provider immediately to reschedule the dose as soon as possible.
• Do not attempt to self-administer a missed dose.

• Keep NEOSURF 100MG INJ 3ML away from the reach of children and pets.
• Store NEOSURF 100MG INJ 3ML in a refrigerator (2 - 8°C). Do not freeze.

• **Use Under Medical Supervision:** NEOSURF 100MG INJECTION 3 ML should only be administered by trained healthcare professionals in a hospital or clinical setting. Self-administration is strictly prohibited due to the potential for serious side effects.
• **Monitor Vital Signs:** During and after NEOSURF 100MG INJECTION 3 ML administration, closely monitor the patient's vital signs, including blood pressure, heart rate, and respiratory rate. Report any significant changes or abnormalities to the medical team immediately.
• **Inform Your Doctor About Existing Conditions:** Before receiving NEOSURF 100MG INJECTION 3 ML, inform your doctor about all your existing medical conditions, including heart problems, kidney disease, liver disease, or any allergies. This will help them assess the risks and benefits of the medication.
• **Be Aware of Potential Side Effects:** NEOSURF 100MG INJECTION 3 ML may cause side effects such as nausea, vomiting, headache, dizziness, or injection site reactions. Report any persistent or severe side effects to your doctor promptly. Also, inform your doctor if you experience any allergic reactions like rashes, itching, or swelling.
• **Drug Interactions:** Inform your doctor or pharmacist about all other medicines, herbal products, and supplements you are currently taking before starting NEOSURF 100MG INJECTION 3 ML. This is important to avoid potential drug interactions that may affect the medication's effectiveness or increase the risk of side effects. Some medicines may interfere with how NEOSURF 100MG INJECTION 3 ML works.

• NEOSURF 100MG INJECTION 3 ML is administered by a healthcare professional, so food interactions are unlikely. However, always inform your doctor about all medications, supplements, and dietary habits before receiving the injection.